2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development
Date：April 25, 2019
The new era of Artificial Intelligence (AI) is coming. In the CMU-NUS Joint Symposium, President Mien-Chie Hung of China Medical University (CMU) encouraged the participants to grasp the trend of future technology, apply big data and AI into the research of new drug development to shorten the development time and increase the odds of success.
China Medical University (CMU) and National University of Singapore (NUS) held the CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development on April 24th, 2019. Dr. Fred Wong, Head of NUS Department of Pharmacology, Professor Christina Chai, Head of NUS Department of Pharmacy, and Dr. Edward Chow from Cancer Science Institute, National University of Singapore, participated in the symposium with the invitation from Professor Liang-Yo Yang, Dean of Global Affairs, CMU. Over 50 CMU faculty members, postdocs and graduate students enthusiastically engaged in the symposium.
“The best way to promote advances in science and technology is the face-to-face idea-exchanging among scholars and researchers. This CMU-NUS joint symposium focuses on herbal medicine and new drug development, and new drug development researches will be facilitated by AI. I hope this symposium not only enhances international academic exchanges and our friendship, but also strengthens our cooperation in scientific research,” said President Mien-Chie Hung in his opening remarks.
“Since the 2nd CMU-NUS Joint Symposium last year, CMU and NUS have both provided funding to support four projects. Hopefully, there will be more cooperative projects in the field of herbal medicine and new drug development after this joint symposium,” said CMU Vice President Lu-Hai Wang.
Nine presentations were delivered in the 2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development:
Hung-Rong Yen (Associate Dean, College of Chinese Medicine, CMU):
Develop New Drug Targeting IL-17 for the Treatment of Psoriasis from Indigo Naturalis
Shih-Chieh Hung (Director, New Drug Development Center, CMU):
Human Mesenchymal Stem Cells and its Roles in Therapeutics
Hsiang-Wen Lin (Associate Dean, College of Pharmacy, CMU):
An Overview of the Small-Molecule Drug Discovery Program
Yuh-Pyng Sher (Associate Professor, Graduate Institute of Biomedical Sciences, CMU):
Targeting Metastatic-Associated Pathways for Cancer Treatment: the Impact of ADAM9 (A Disintegrin and Metalloproteinase 9)
Heng-Hsiung Wu (Assistant Professor, Graduate Institute of Biomedical Sciences, CMU):
Targeting the Mechanistical Process of IL-17B/IL-17RB Oncogenic Signaling for Pancreatic Cancer Treatment
Min-Tsang Hsieh (Assistant Professor, School of Pharmacy, College of Pharmacy, CMU):
New Bis(hydroxymethyl) Alkanoate Curcuminoid Derivatives Exhibit Activity Against Triple-Negative Breast Cancer in Vitro and in Vivo
Christina Chai (Head, Department of Pharmacy, National University of Singapore):
Drug Discovery and Development Research in NUS Pharmacy
Wai-Shiu Fred Wong (Head, Department of Pharmacology, National University of Singapore):
Overview of the Drug Discovery & Optimization Platform in NUHS
Edward Kai-Hua Chow (Assistant Professor, Cancer Science Institute, National University of Singapore):
AI-Based Drug Combination Optimisation for Drug Development and Personalised Medicine
Representatives from both universities showed strong interests in each other’s research topics and there was a heated discussion after each session. There are some similarities between the researches done by CMU and NUS, but there are also quite a few aspects that are complementary. Therefore, both CMU and NUS will surely benefit from establishing cooperation in the field of herbal medicine and new drug development.
Moreover, both universities agreed to combine the research expertise of CMU’s Research Center for Chinese Herbal Medicine, New Drug Development Center, and NUS’s Pharmaceutical Innovation & Research Centre. CMU and NUS will both invest more research resources and put efforts in developing anti-inflammatory drugs for asthma and arthritis, apply QPOP to sort out effective herbal medicine that can boost or regulate immune function, and probe into the possible effects of acupuncture on patients with chronic obtrusive pulmonary disease (COPD).
Before the joint symposium, Dean Liang-Yo Yang and Associate Dean Hung-Rong Yen arranged a visit for the three NUS researchers and led them to the Chinese Medicine Hospital and Chinese Medicine Pharmacy of China Medical University Hospital (CMUH). The NUS researchers were very impressed with the trauma treatment, acupuncture treatment, and the pulse and tongue diagnosis assisted by modern instruments. In addition, they highly appreciated the successful integration of Chinese and western medicine in the healthcare service provided by CMUH. The NUS researchers expressed their intention to closely collaborate with CMU and CMUH, and appoint CMU professors specialized in integrated medicine to lecture at NUS to enhance bilateral collaboration and promote NUS medical students’ understanding of traditional Chinese medicine and Chinese herbal medicine.
China Medical University hosted 2019 CMU-NUS Joint Symposium in Herbal Medicine and New Drug Development